Zhengye Biotechnology Holding Balance Sheet (2023-2025) | ZYBT

Balance Sheet Dec2023 Dec2024 Jun2025
Assets
Current Assets
Cash & Equivalents 2.09M2.59M2.57M
Short-term Investments 1.68M278.43276.51
Cash & Current Investments 3.78M2.59M2.57M
Receivables - Net 12.89M8.29M5.11M
Receivables - Other 0.18M0.10M0.10M
Receivables 13.07M8.39M5.21M
Raw Materials 1.37M1.03M
Work In Process 4.66M4.60M
Finished Goods 2.06M2.47M
Inventory 8.10M8.11M7.40M
Prepaid Assets 1.50M-3.23M
Current Assets 26.28M24.72M27.85M
Non-Current Assets
Buildings 21.08M21.29M
Construction in Progress 1.06M1.36M
Property, Plant & Equipment (Net) 36.56M35.52M34.11M
Long-Term Investments 37.89M39.53M
Intangibles 8.91M2.07M2.12M
Goodwill & Intangibles 8.91M2.07M2.12M
Long-Term Deferred Tax 1.65M1.53M2.26M
Other Non-Current Assets 0.90M2.60M2.35M
Non-Current Assets 43.14M43.95M41.92M
Assets 69.43M68.67M69.77M
Liabilities
Current Liabilities
Accounts Payables 6.34M5.98M5.92M
Notes Payables 11.09M10.36M11.18M
Dividends payables 2.17M
Payables 19.61M16.34M17.10M
Accumulated Expenses 0.78M0.52M
Other Accumulated Expenses 0.02M
Short term Debt 11.09M1.00M0.03M
Current Taxes 0.32M0.29M0.30M
Current Deferred Revenue 0.64M0.03M0.14M
Total Current Liabilities 20.87M18.92M18.64M
Non-Current Liabilities
Non-Current Debt 1.39M0.67M0.65M
Minority Interest 9.23M9.55M9.15M
Other Non-Current Liabilities 4.54M4.51M
Total Non-Current Liabilities 1.44M0.67M0.65M
Total Liabilities 22.31M19.59M19.29M
Shareholder's Equity
Total Debt 12.48M1.67M0.68M
Common Equity 47.12M49.08M
Shareholder's Equity 47.12M49.08M50.48M
Liabilities and Shareholders Equity 69.43M68.67M69.77M
Retained Earnings 5.33M6.70M3.66M